MabSpace Biosciences Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 60
Employees
  • Latest Deal Type
  • Merger of Eq.

MabSpace Biosciences General Information

Description

Developer of antibody based therapeutics designed to treat cancer and fibrotic disorders affecting lung, kidney and liver. The company's therapeutics are based on its proprietary immune tolerance breaking technology (IMBT) that generates lead antibodies with diverse epitopes that targets different components of the tumor microenvironment, enabling physicians to treat cancer and fibrotic diseases with a better medical outcome.

Contact Information

Website
www.mabspacebio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Transcenta Holding
Primary Office
  • Room B6-501, Bio-Nano Park
  • No.218 Xinghu Street, Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MabSpace Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger of Equals 02-Jan-2019 0000 Completed Generating Revenue
2. Early Stage VC (Series B1) 09-Feb-2018 0000 0000 00000 Completed Generating Revenue
1. Early Stage VC (Series A2) 28-Aug-2015 $13M $13M 000.00 Completed Generating Revenue
To view MabSpace Biosciences’s complete valuation and funding history, request access »

MabSpace Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of antibody based therapeutics designed to treat cancer and fibrotic disorders affecting lung, kidney and live
Drug Discovery
Suzhou, China
60 As of 2019
0000
00000000000 0000

00000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
0000000000000
San Diego, CA
000 As of 0000
00000
000000000 - 00000

000000 0

ip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum do
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MabSpace Biosciences Competitors (85)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 000000000 - 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
You’re viewing 5 of 85 competitors. Get the full list »

MabSpace Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MabSpace Biosciences Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
King Star Capital Venture Capital Minority 000 0000 000000 0
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
Sequoia Capital China Venture Capital Minority 000 0000 000000 0
Teng Yue Partners Hedge Fund Minority 000 0000 000000 0
To view MabSpace Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial